ct present study, we investigated genetic divergence between complete autologous H.i v' -1 env genes amdirectly from plasma of two <~ntiretroviral-naive, slow progressing lndi2'1 patients with broad neutralntibody response. All the envelope (Env) clones obtained from one patient (LTl) belonged to subtype C; cond patient (LIS) harbored quasispecies comprised of pure B, C, and B/C recombinants with distinct oints indicative of dual infection with genetically distinct strains. Fu;•her c'uracterization of these Envs provide insight into the biological properties under strong humoral immune respons".
PERSISTENCE OF HJV-1 1.'1 the presence of immense moral immune pressure leads to a remarkable inn diversity in its envelope protein. With progression in ease course, individuals with human immunodefiirus type 1 (HIV -1) infection usually harbor numerous ally rcl;:~ed viral variants tl'rmC...: quasispecies.u Such s arc belit•vcd to eithl'r ddl'rmine disease progresby overcoming t;,e host immune response and/or p resistance to antiretnn·irai therapy agents? 11 The envelope (Env), which play~. key role in the interacth cellular receptors and corcccptors in the viral entry , remains exposPd on the virus surface under incessant lective pressure, particularly thJt of thl' autologous izing antibodies. The continual e\·olution of viral ecies by mutation poses an impediment in successful ition both by virus-specific cellular and humoral imechanisms. 12 ' 13 In addition, virul sequence diversity es complex shape throu~h recombination, particularly s of dual infection 11 ·H 19 by dif/C'rent subtypes. Studies diversity would provide information on selective forh as hu~oral immtmity that might influence the rate of ssion of disease and also would help in the identifi.cadeterminants on the Env protein that modulate v1ral se to immune pressure such as neutralizing antibodies.
we investigated the genetic propert1es of rnv genes reting viral quasispecies amplified from plasma of two roviral treatment (ART)-nuive slow progressmg lnd1an ts with broadly neutralizing antibody response .
First, the neutralization potential of plasma specimens obtained from the two slow progressing patients (NARI-LTl and NARI-l T5) was examined against 28 Env-pseudotyped viruses comprising tier-1, .ier-2, and tier-3 viruses as described previously 20 Plasma samples were diluted in growth media (DMEM supplemented with 5% fetal bovine sera; Invitrogen Inc.) starting from a 1:20 dilution and incubated ·with Env-pscudot)yed viruses for 1 hat 37°C. Subsequently 1 x 10 4 TZM-bl cclls 2 were added to this mixture in 96-well tray tissue cultun• plates supplemented with 25 11g/ml DEAE Dextran (Sigma Inc.) and further incubated for additional 2 days at 37°C in a C0 2 incubator. The degree of neutralization of Env-pseudotyped viruses of TZM-bl cells in the presence of L T1 and l T5 plasma was determined by measuring the reduction in rc 1 Jtive luminescence units (RLU) as described earlier. 2 ' 1 As shown in Table L the majority of viruses tested here were significantly neutralized by LTS plasma; L T1 plasma also showed substantial neutralization potential albeit to a lesser extent than LTS plasma. Of viruses, 16/28 showed 50% neutralization in 1:100 LTl plasma dilutions while 11/28 vimses showed 50% neutralization at 1:500 dilutions and up to 1:5361 dilutions. On the other han-:!, 21/28 viruses showed 50% neutralization to LT5 plasma at 1:100 [including P:'0.03 (tier 3 virus) and JRFL (tier 2 virus)], while 12/28 vuuses showed 50% neutralization at 1:500 and up to 1:8210. Overall, LTS plasma was found to be a better neutra~~r than LTl, although both of them showed broad neutralizmg property against the vimses tested here. We next examined the genetic properties of Env obtained from these two patients harboring broadly neutralizing antibodies ( Table 2 ). Complete gpl60 was amplified from reverse transcribed plasma viral RNA of both samples in the presence of high fidelity proofreading polymerase. Platinum Taq (Invitrogen Inc.). The gpl60 amplicons were cloned in either pcDNAS.lTOPO (Invitrogen, Inc.) or in pSVIIIenv as described previousl)^^'' ( Table 2) . For patient LTl, Env clones were obtained from two different time points-2007 and 2009. Due to unavaUabihty, we were able obtain Envs from patient LT5 at only one time point (2007) . More than cne Env clone was obtained from each plasma specimen. DNA sequences of patient Env clones were obtained through Genetic Analyzer 3130XL (Applied Biosystems, Life Tecfinologies Inc.) using Big D)'e terminator as described previously.^ The genetic properties are summarized in Table 1 . We found that in regard to patient LTl, all the Envs were found to have comparable potential N-linked glycosylatton sites (PNLGS) (between 26 and 27); however, for patient LT5, the PNLCs ranged from 25 to 34, indicating a variation in the glycosylation pattern in viral quasispedes in this patient. The V1V2 loop length also varied betwevii the LT5 Envs, while it remained comparable in that of patient LTl. The V3 loop charge of LTl Envs ranges from -1-3 to -i-S and all possessed the GPGQ motif at the tip of the V3 loop; however, in case of LT5 Envs, the V3 loop charge ranged from -(-2 to -1-7 and six of them (LT5.J3, LT5.J1U, LT5.J11, LT5.J13, LT5.J24, and LT5.J25) were found to contain the GPGR motif. Out of 10 LTl Env clones, all but two (LT1_07.J10 and LT1_07.J15) showed in-fectivit>' m TZM-bl cells that express CD4, CCR5, and CXCR4. On the other hand, only 4/14 Env clones (LT5.J3b, LT5.J4b, LT5.J7b, and LT5.I12) obtained from LT5 plasma showed infectivity in TZM-bl cells. Other Envs showed infectivity below V3   35  36  35  35  35  35  35  35  35  35  35  35  35  35  34  35  35  35  35  35  35  35  35   V4   28  28  28  29  29  21  28  21  28  35  26  26  32  26  35  35  26  35  26  35  35  26  26   V5   11  11  11  12  11  11  11  11  11  13  13  14  13  14  13  13  13  13  12  13  13  12  12   PNLGS   V3  loop  gp41 (gpl60) charge   352  352  352  352  352  352  352  352  352  345  352  345  345  352  345  345  345  345  345  345  345  345  345   27  27  26  27  27  27  27  27  27  26  32  32  25  32  26  26  34  26  34  26  27  34  34   3  5  3  3  3  4  3  4  3  7  3  2  4  4  6  6  3  6  3  6  6  3  3   V3tip   GPGQ  GPGQ  GPGQ  GPGQ  GPGQ  GPGQ  CPGQ  GPGQ  GPGQ  GPGR  GPGQ  GPGQ  GPGQ  GPGQ  GPGR  GPGR  GPGQ  GPGR  GPGQ  GPGR  GPGR  GPGQ  GPGQ   CoR  usage   CCR5  CCR5  CCR5  NF  NF  CCR5  CCR5  OCR?  CCR5  NF  CCR5  NF  CCR5  CCR5  NF  NF  CCR5  NF  NF  NF  NF  NF  NF PNLGS, potential N-linked glycosylation sites; CoR, coreccptor usage; NF, nonfunctional Env clones; ART, antiretroviral therapy.
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an acceptable range. All the functional Env clones from both LTl and LT5 were found to be CCR5 tropic (Table 1) . Nonetheless, LT5 Envs that contained the GPGR motif in the V3 loop and possessed a net positive charge of greater than 6 in the V3 loop revealed the presence of viral quasispecies that were presumably CXCR4 using. Importantly, two of the Env clones (LT5.J6 and J28) showed premature stop codons, indicating the presence of defective Envs in this patient.
For analysis of intrapatient genetic divergence of Env clones, the deduced amino acid sequences were subjected to phylogenetic analysis using the neighbor-joining method with Kimura two-parameter using MEGA software (version 4). As shown in Fig. 1 , for patient LTl, Env^ obtained al the first time point (2007) clustered closely, while those obtained after 2 years (2009) were found to diverge away from Envs obtained in 2007. Interestingly, two of the Env clones (l.Tl-09.J3 and J8) obtained at the second time point (2009) showed significant deviation from the other Env clones ohtaincu at the same time point. Indeed, all the Env clones belonged to subtype C. On the ether hand, Env clones obtained from patient LT5 were found to be composed of pure clades B and C and B/C recombinants as identified by the Recombinant Identification Program (RIP; www.hiv.lanl.gov) leading to greater intrapatient genetic diversity in comparison to LT-1 Envs. While pure clade C (LT5.J3B and LT5.J7B) and pure clade B (LT5.J3, LT5.J24, and LT5.J25) Envs clustered closely with the respective subtype reference strains in the phylogenetic tree ( Fig. 1) , others varied considerably.
We further examined the percent similarity of nucleotide sequences of autologous Env clones using SimPlot analysis.^ As shown in Fig. 2 , in case of LTl En\'s, LT1-09.J3 and LTl-09.J8 were found to differ significantly from the other LTl Envs, suggesting considerable evolution of Env during this period. SimPlot analjreis of LT-5 revealed that LT5.J4 and LT5.J4B were found to be clearly distinct between nucleotide positions 1000 and 1200. Although the LTl complete Envs form a monophyletic cluster, when examined for domain-wise divergence, Envs obtained in 2009 (after 2 years) were found to diverge with respect to the variable loops and gp41 (data not shown). With regard to patient LT5, significant divergence in Env sequences in variable loops and gp41 '.-.as also found (data not shown). The divergence in LT5 Envs was prcbumably due to differences in subtypes and recombination in Env.
We next examined whether Env clones obtained from both LTl and LT5 patients despite having genetic distances represented descendants closest to a common ancestor of the members of the group. For this, deduced amino acid of gpl20 sequences of the Env clones was aligned with limited clade B and clade C global gpl20 sequences and bootstrapped phylogenetic trees were constructed using the neighbor-joining method using MEGA (Version 4). As shown in Fig. 3 , LTl Env clones clustered closely to the Indian clade C, indicating that they evolved from a common ancestor. However, we found that LT5 Envs clustered with both subtype C and subtype B gpl20 sequences; clade B sequences were close to Thai B sequences and clade C were closely clustered near Indian subtype C. Ihe Env clone LT5.J4B gpl60 sequence was found to diverge from the rest of the LT5 Envs. Our observation indicated that this pai licular patient LT5 was dually infected with different strains, possibly with Thai B and Indian C strains.
LT1 LT5
FIG. 1. Genetic relatedness of autologous Envs. Deduced amino acid sequences of Env clones were used to prepare bootstrapped phylogenetic trees using MEGA4.1. and had likely undergone recombination during the course of infection.
To further analyze the genetic relatedness of recombinant LT5 Envs, we studied the breakpoints. The amino acid sequences were thus subjected to breakpoint analysis through the jpHMM (jumping profile Hidden Markov Model) web server at GOBICS (http.V/jphmm.gobics.de) and using the breakpoints, the recombinant structures of each Env were drawn (Fig. 4) using the recombinant HIV-1 drawing tool (http;//www.hiv.lnnl.gov/content/scquence/DRAW_CRF/ recom_mapper.html) available at the HIV Los Alamos database (www.hiv.lanl.gov) to precisely dissect the position of recombination. As shown in Fig. 4, LT5 .J3, J24 and J25 were found to possess Env of pure subtype B while only LT5.J3B and 7B contained pure subtype C Env. The rest of the autologous Envs were found to be mosaic in nature with distinct breakpoints between subtypes B and C. LT5.J4B was found to possess three breakpoints [5954-6495 (subtype B), 6495-7414 (subtype C), and 7414-8821 (subtype B)]; this recombination pattern was likely responsible for its significant deviation from other autologous Envs in the phylogenetic tree.
In conclusion, we report attributes of env genes amplified directly from plasma of two ART-naive HIV-positive slow progressing individuals. The two individuals were found to possess neutralizing plasma with considerable breadth. Both LTl and LT5 plasma showed a fair degree of potency but subty^pe bias toward clade C Envs, especially LTl plasma. Nonetheless, LT5 plasma was found to provide 50% neutralization with tier-2 and tier-3 Envs (JRFL and PVO.04), indicating that patient LT5 indeed harbored broad neutralizing antibody.
Phylogcnctic tree of LT-5 sequences (Fig. 3 ) revealed that the Env variants were distinctly separated and clustered with epidemiologically unlinked reference viruses. Additionally, a multiregion hybridization assay (MHAbce v2)^^ using LT-5 plasma also indicated recombination events in Env, suggesting that recombinant Env quasispedes constitute a major portion in the plasma (data not shown). It is unclear as to what impar* dual infection has on disease progression. Results of previous studies^"*^ "^^ suggested that superinfection by two different strains tends to result in faster disease progression and it was hypothesized that dual infection facibtates/accelerates viral adaptation and exploitation of cellular niches that would take many years to develop from a homogeneous infecting strain. Interestingly, in our study, we found the presence of distinct subtype B and C strains in the viral quasispedes in plasma in an antiretrovrral-naive patient infected for more than 8 years. We cilso obtained evidence of Env clones from patient LT5 with premature stop codons. This indicated that this particular patient was infected with strains that gave rise to few defective virions. Similar observations were reported by Braibant et a/.'' and Wang et al:
Our findings are sigriificant as these env genes represent viral quasispedes that were in drculation and were under immense humoral immune pressure, in contrast to the reports by Braibant et al. ^^ in which they characterized Envs from proviral DNA that may not necessarily represent drculating viruses. Further analysis of these Env variants obtained from both the patients would help characterize factors that modulate replication and also identify important targets for virus neutralization.
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